Answers are grounded in this paper and cite their sources.
Among overweight or obese adults, orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide, compared with placebo, were each associated with achieving at least 5% weight loss at 52 weeks. Phentermine-topiramate and liraglutide were associated with the highest odds of achieving at least 5% weight loss.
No takes yet. Share an insight, caveat, or question.
Khera et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: